All you want to know about Mycobacterium abscessus
Emmanuelle Cambau(Inserm), Kevin Winthrop(Oregon Health & Science University), Jakko van Ingen(Radboud University Nijmegen), Jean‐Louis Herrmann(Inserm), Giovanni Delogu(Università Cattolica del Sacro Cuore)
Cited by 7
Related Papers
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k
2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
|Arthritis Care & Research|2012|1.8k
Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline
|European Respiratory Journal|2020|876
Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline
|Clinical Infectious Diseases|2020|828